HISTORY OF AFT PHARMACEUTICALS AFT Pharmaceuticals is a 100% privately owned pharmaceutical company operating in Australia and New Zealand with full development, regulatory and sales/marketing operations. In addition to distributing agency lines, AFT owns a significant portfolio of IP (trademarks, patents) and product licenses. AFT markets patented, branded & generic drugs and is also involved in drug development. 1998 – started in NZ with first sales made 2000 – acquired shareholdings in 2 South African Pharmaceutical Companies and a wholesaler 2002 – acquired first AFT wholly owned products 2004 – started Australian company and exited South Africa Investment 2004 – started drug development work and filed first 2 global patents 2006 – JV drug development agreement with an EU based company 2008 – Secured a licensing deal for 3 AFT products in SE Asia. Dec08, first launches in Malaysia 2009 – Global licensing negotiations for key development project 2009 – Launch of world first combination analgesic - Maxigesic – into New Zealand Group Sales for Mar 2010 year will be over $37 million Our objective is to build a significant Australasian Pharmaceutical company and to license our first, novel patented, drug development globally